RA Capital Management is a Boston-based investment firm founded in 2004 that makes public and private investments in healthcare. See contact routes.
RA Capital Management is a Boston-based investment firm founded in 2004 that makes public and private investments in healthcare, biotechnology, and planetary health industries[2][4]. The firm employs an evidence-based, science-led investment thesis across all stages, targeting companies developing drugs, medical devices, diagnostics, services, and research tools primarily in the United States and Europe[2][4][5]. RA Capital operates as a hybrid manager combining venture capital and long/short hedge fund strategies, though specific typical check sizes and lead/follow behavior are not explicitly detailed in available sources[5][9]. Notable portfolio companies include Moderna Therapeutics, Bluebird Bio, 89bio, and Audentes Therapeutics, with the firm having led 28 of its 114 total investments as of December 2019[11]. The firm distinguishes itself through its commitment to "evidence-based investing" and has expressed a growing interest in climate and sustainability technologies alongside its core healthcare focus[4][12]. RA Capital maintains offices in Boston, San Francisco, and New York, and directs startup pitches through a centralized hub team at request@racap.com[3][6].
Every field above is read from the StartupFundraising firm directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with comparable investors when building a target list.
Investors like RA Capital Management · Full investor directory · Investor access · Company funding database